1-5 of 5
Wen-Bing Duan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Does intensive consolidation confer a clinical advantage over continued less intensive therapy in elderly patients with Acute Myeloid Leukemia in first remission following azacitidine plus venetoclax induction?

Free
Zongru Li, Lu Yu, Lijuan Hu, Xiaoning Gao, Zhenling Li, Wanling Sun, He-Bing Zhou, Liping Dou, Liangding Hu, Yujun Dong, Hongmei Jing, Hui Liu, Jingbo WANG, Li Bao, Hanyun Ren, Zhao Ting, Wen-Bing Duan, Hao Jiang, Feifei Tang, Shasha Zhao, Xiaojun Huang, Qian Jiang
Journal: Blood
Blood (2025) 146 (Supplement 1): 5162.
https://doi.org/10.1182/blood-2025-5162
Published: 2025
Journal Articles

Integrating EVI1 expression into prognostic models for MDS: Insights from IPSS-R and IPSS-m subgroup analyses

Free
Xiaohang Ma, Wen-Bing Duan, Qi Chen, Ya-Zhen Qin, Hao Jiang, Qian Jiang, Ying-Jun Chang, Xiaojun Huang, Xiaosu Zhao
Journal: Blood
Blood (2025) 146 (Supplement 1): 3479.
https://doi.org/10.1182/blood-2025-3479
Published: 2025
Journal Articles

Safety and efficacy of venetoclax plus CAG (cytarabine, aclarubicin, G-CSF) regimen in patients with relapsed or refractory Acute Myeloid Leukemia: A prospective single-arm phase II study

Free
Wen-Jing Yu, Wen-Bing Duan, Qi Chen, Xuying Pei, Jinsong JIA, Jing Wang, Xiaolu Zhu, Xiaosu Zhao, Xiaojun Huang, Hao Jiang
Journal: Blood
Blood (2025) 146 (Supplement 1): 1680.
https://doi.org/10.1182/blood-2025-1680
Published: 2025
Journal Articles

Oral etoposide vs intravenous daunorubicin plus ATRA-RIF as induction therapy for low-risk acute promyelocytic leukemia: A phase II randomized controlled Trial

Free
Xiaolu Zhu, Zhao Ting, Wen-Bing Duan, Qi Chen, Jing Liu, Wen-Jing Yu, Xiaosu Zhao, Ya-Zhen Qin, Hong-Xia Shi, Ying-Jun Chang, Xiaojun Huang, Hao Jiang
Journal: Blood
Blood (2025) 146 (Supplement 1): 1671.
https://doi.org/10.1182/blood-2025-1671
Published: 2025
Journal Articles

A Completely Oral Regimen Including Oral Etoposide As Cytoreductive Chemotherapy Combined with All Trans Retinoic Acid and Oral Arsenic for Induction Therapy in Patients with High-Risk APL：Comparable to Intravenous Cytoreductive Therapy

Free
Feifei Tang, Wen-Bing Duan, Xiao-Hong Liu, Sheng-Ye Lu, Xiao-Su Zhao, Ya-Zhen Qin, Jin-Song Jia, Jing Wang, Li-Zhong Gong, Qian Jiang, Zhao Ting, Hong-Xia Shi, Ying-Jun Chang, Xiao-Jun Huang, Hao Jiang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4288.
https://doi.org/10.1182/blood-2023-188657
Published: 2023